Patent details

301070 Product Name: recombinant human monoclonal IgG1 antibody against programmed death ligand-1

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301070
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3225632
Status:
Refused Art. 10 of the EC Regulations
Application number:
301070
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/17/1214
Marketing Authorization Type:
EEA
Marketing Authorization Date:
20/09/2017
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
05/11/2020
First Marketing Authorization date:
20/09/2017
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
05/11/2020
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
28/06/2021

Applicant/holder

From:
05/11/2020
 
 

 

Name:
Mayo Foundation for Medical Education and Research
Address:
200 First Street S.W., Rochester, MN 55905, United States of America (US)

Agent

Name:
ir. W.J.J.M. Kempes
From:
05/11/2020
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
26/21
Publication date:
30/06/2021
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
46/20
Publication date:
11/11/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
28/06/2021 Outgoing Correspondence Decision refusal 3 PDF /2/4/1/0/2/0800620142/docs/301070_8_419684l527a.pdf
22/03/2021 SPC Documents Mail SPC 3 PDF /2/4/1/0/2/0800620142/docs/301070_3_supplprotectioncertificate20210322050054173.pdf
23/12/2020 Outgoing Correspondence Letter to applicant 3 PDF /2/4/1/0/2/0800620142/docs/301070_2_386121l173.pdf
09/11/2020 Publication Publication 1 PDF /2/4/1/0/2/0800620142/docs/301070_5_i1document20201109090828309.pdf
09/11/2020 Front Page Front Page 1 PDF /2/4/1/0/2/0800620142/docs/301070_9_i1frontpage20201109090827832.pdf
09/11/2020 Outgoing Correspondence Confirmation receipt request 1 PDF /2/4/1/0/2/0800620142/docs/301070_14_376592l174.pdf
05/11/2020 SPC Documents Annex SPC 4 PDF /2/4/1/0/2/0800620142/docs/301070_0_supplprotectioncertificate20201105123958250.pdf
05/11/2020 SPC Documents Accompanying letter SPC 3 PDF /2/4/1/0/2/0800620142/docs/301070_1_supplprotectioncertificate20201105123957961.pdf
05/11/2020 SPC Documents Marketing Authorization SPC 4 PDF /2/4/1/0/2/0800620142/docs/301070_4_supplprotectioncertificate20201105123958020.pdf
05/11/2020 Application Form First filed application form 3 PDF /2/4/1/0/2/0800620142/docs/301070_6_applicationform20201105123957810.pdf
05/11/2020 SPC Documents Annex SPC 12 PDF /2/4/1/0/2/0800620142/docs/301070_7_supplprotectioncertificate20201105123958304.pdf
05/11/2020 SPC Documents Annex SPC 17 PDF /2/4/1/0/2/0800620142/docs/301070_10_supplprotectioncertificate20201105123958378.pdf
05/11/2020 SPC Documents Annex SPC 11 PDF /2/4/1/0/2/0800620142/docs/301070_11_supplprotectioncertificate20201105123958081.pdf
05/11/2020 SPC Documents Summary of the characteristics of the product 19 PDF /2/4/1/0/2/0800620142/docs/301070_12_supplprotectioncertificate20201105123958191.pdf
05/11/2020 SPC Documents Annex SPC 1 PDF /2/4/1/0/2/0800620142/docs/301070_13_supplprotectioncertificate20201105123958137.pdf